Medical device maker Medtronic (MDT) reported a solid quarter Tuesday morning, but its stock was down a fraction on the stock market today as its profit margins showed signs of weakness. For its fiscal Q2 ended Oct. 25, Medtronic made 91 cents a share, up 3.4% from the year-earlier quarter and a penny over analysts’ consensus. Sales rose 2.4% to $4.2 billion, in line with consensus. The company reiterated its guidance for the full fiscal year,
Read More:
Medtronic Q2 Earnings Beat, But Profit Margins Soft